Valion Bio (VBIO) EBT Margin (2021 - 2025)
Valion Bio (VBIO) posted EBT Margin of -1697.95% for Q3 2025, down 562.23 percentage points from -1135.71% a year earlier but up 249.73 percentage points from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) EBT Margin (2021 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, EBT Margin at Valion Bio was -1234.85%, down 563.80 percentage points year-over-year; for FY2024, it came in at -573.08%, up 127.94 percentage points from FY2023.
- Annual EBT Margin shows a three-year change of -124.95 percentage points (FY2021 to FY2024).
- In prior years, Valion Bio's EBT Margin was -701.02% in FY2023 (-152.32 pp), -548.70% in FY2022 (-100.57 pp) and -448.13% in FY2021.
- Quarterly EBT Margin has run from a low of -2151.43% in Q1 2025 to a high of -162.22% in Q4 2024 over five years.
- On a year-over-year basis, EBT Margin has declined in each of the last three quarters, with an average year-over-year change of -362.45 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2024, with a gain of 466.35 percentage points; the weakest was Q1 2025, with a drop of 1708.02 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -1947.67% (Q2 2025), -2151.43% (Q1 2025) and -162.22% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,697.95% |
| Jun 30, 2025 | -1,947.67% |
| Mar 31, 2025 | -2,151.43% |
| Dec 31, 2024 | -162.22% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -904.29% |
| Mar 31, 2024 | -443.41% |
| Dec 31, 2023 | -628.57% |
| Sep 30, 2023 | -624.11% |
| Jun 30, 2023 | -1,319.88% |
| Mar 31, 2023 | -562.77% |
| Dec 31, 2022 | -552.94% |
| Sep 30, 2022 | -541.72% |
| Jun 30, 2022 | -571.59% |
| Mar 31, 2022 | -523.60% |
| Dec 31, 2021 | -589.20% |
| Sep 30, 2021 | -443.68% |
| Jun 30, 2021 | -476.87% |
| Mar 31, 2021 | -419.81% |
API Access
Valion Bio EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();